Spinal cord injury reprograms muscle fibroadipogenic progenitors to form heterotopic bones within muscles

Abstract

The cells of origin of neurogenic heterotopic ossifications (NHOs), which develop frequently in the periarticular muscles following spinal cord injuries (SCIs) and traumatic brain injuries, remain unclear because skeletal muscle harbors two progenitor cell populations: satellite cells (SCs), which are myogenic, and fibroadipogenic progenitors (FAPs), which are mesenchymal. Lineage-tracing experiments using the Cre recombinase/LoxP system were performed in two mouse strains with the fluorescent protein ZsGreen specifically expressed in either SCs or FAPs in skeletal muscles under the control of the Pax7 or Prrx1 gene promoter, respectively. These experiments demonstrate that following muscle injury, SCI causes the upregulation of PDGFRα expression on FAPs but not SCs and the failure of SCs to regenerate myofibers in the injured muscle, with reduced apoptosis and continued proliferation of muscle resident FAPs enabling their osteogenic differentiation into NHOs. No cells expressing ZsGreen under the Prrx1 promoter were detected in the blood after injury, suggesting that the cells of origin of NHOs are locally derived from the injured muscle. We validated these findings using human NHO biopsies. PDGFRα⁺ mesenchymal cells isolated from the muscle surrounding NHO biopsies could develop ectopic human bones when transplanted into immunocompromised mice, whereas CD56⁺ myogenic cells had a much lower potential. Therefore, NHO is a pathology of the injured muscle in which SCI reprograms FAPs to undergo uncontrolled proliferation and differentiation into osteoblasts.

References

[1] Ohlmeier M et al. Muscle localization of heterotopic ossification following spinal cord injury. Spine J., 2017, 17: 1519-1522

[2] Genet F et al. Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries. PLoS One, 2011, 6: e16632

[3] Wittenberg, R. H., Peschke, U. & Botel, U. Heterotopic ossification after spinal cord injury. Epidemiology and risk factors. J. Bone Joint Surg. Br. 74, 215–218 (1992).

[4] Reznik JE et al. Prevalence and risk-factors of neurogenic heterotopic ossification in traumatic spinal cord and traumatic brain injured patients admitted to specialised units in Australia. J. Musculoskelet. Neuronal Interact., 2014, 14: 19-28

[5] van Kuijk, A. A., Geurts, A. C. & van Kuppevelt, H. J. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord. 40, 313–326 (2002).

[6] Forsberg, J. A. et al. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J. Bone Joint Surg. Am. 91, 1084–1091 (2009).

[7] Sakellariou VI, Grigoriou E, Mavrogenis AF, Soucacos PN, Papagelopoulos PJ. Heterotopic ossification following traumatic brain injury and spinal cord injury: insight into the etiology and pathophysiology. J. Musculoskelet. Neuronal Interact., 2012, 12: 230-240

[8] Citak M et al. Risk factors for heterotopic ossification in patients with spinal cord injury: a case-control study of 264 patients. Spine, 2012, 37: 1953-1957

[9] de l’Escalopier, N., Salga, M., Gatin, L., Genêt, F. & Denormandie, P. Resection of heterotopic ossification around the hip after trauma. EFORT Open Rev. 4, 263–268 (2019).

[10] Vanden Bossche, L. & Vanderstraeten, G. Heterotopic ossification: a review. J. Rehabil. Med. 37, 129–136 (2005).

[11] Bradleigh LH et al. Deep venous thrombosis associated with heterotopic ossification. Arch. Phys. Med. Rehabil., 1992, 73: 293-294

[12] Salga M et al. Sciatic nerve compression by neurogenic heterotopic ossification: use of CT to determine surgical indications. Skelet. Radio., 2015, 44: 233-240

[13] Genet F et al. Impact of the operative delay and the degree of neurologic sequelae on recurrence of excised heterotopic ossification in patients with traumatic brain injury. J. Head. Trauma Rehabil., 2012, 27: 443-448

[14] Genet, F. et al. Impact of late surgical intervention on heterotopic ossification of the hip after traumatic neurological injury. J. Bone Joint Surg. Br. 91, 1493–1498 (2009).

[15] Haran, M., Bhuta, T. & Lee, B. Pharmacological interventions for treating acute heterotopic ossification. Cochrane Database Syst. Rev. 18, CD003321 (2004).

[16] Teasell RW et al. A systematic review of the therapeutic interventions for heterotopic ossification after spinal cord injury. Spinal cord., 2010, 48: 512-521

[17] Alexander KA, Tseng H-W, Salga M, Genêt F, Levesque J-P. When the nervous system turns skeletal muscles into bones: How to solve the conundrum of neurogenic heterotopic ossification. Curr. Osteoporos. Rep., 2020, 18: 666-676

[18] Debaud C et al. Local and systemic factors drive ectopic osteogenesis in regenerating muscles of spinal-cord–injured mice in a lesion-level–dependent manner. J. Neurotrauma, 2021, 38: 2162-2175

[19] Genêt F et al. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle. J. Pathol., 2015, 236: 229-240

[20] Alexander KA et al. Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury. Front. Immunol., 2019, 10: 377

[21] Torossian F et al. Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications. JCI insight, 2017, 2: e96034

[22] Günther S et al. Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells. Cell Stem Cell, 2013, 13: 590-601

[23] Montarras D et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science, 2005, 309: 2064-2067

[24] Sambasivan R et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development, 2011, 138: 3647-3656

[25] Joe, A. W. et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153–163 (2010).

[26] Wosczyna MN et al. Mesenchymal stromal cells are required for regeneration and homeostatic maintenance of skeletal muscle. Cell Rep., 2019, 27: 2029-2035.e2025

[27] Lemos DR et al. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat. Med., 2015, 21: 786-794

[28] Rebolledo, D. L. et al. Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-beta. Matrix Biol. 82, 20–37 (2019).

[29] Contreras, O. et al. The cross-talk between TGF-beta and PDGFRalpha signaling pathways regulates stromal fibro/adipogenic progenitors’ fate. J. Cell Sci. 132, jcs232157 (2019).

[30] Shore EM et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet., 2006, 38: 525-527

[31] Hatsell, S. J. et al. ACVR1^R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci. Transl. Med. 7, 303ra137 (2015).

[32] Dey D et al. Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification. Sci. Transl. Med., 2016, 8: 366ra163

[33] Kan L, Peng C-Y, McGuire TL, Kessler JA. Glast-expressing progenitor cells contribute to heterotopic ossification. Bone, 2013, 53: 194-203

[34] Kan C et al. Gli1-labeled adult mesenchymal stem/progenitor cells and hedgehog signaling contribute to endochondral heterotopic ossification. Bone, 2018, 109: 71-79

[35] Eisner, C. et al. Murine tissue-resident PDGFRalpha+ fibro-adipogenic progenitors spontaneously acquire osteogenic phenotype in an altered inflammatory environment. J. Bone Miner. Res. 35, 1525–1534 (2020).

[36] Lees-Shepard JB et al. Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva. Nat. Commun., 2018, 9

[37] Agarwal, S. et al. Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification. Proc. Natl. Acad. Sci. USA 113, E338–E347 (2016).

[38] Pignolo R, Shore E, Kaplan F. Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects. Orphanet J. Rare Dis., 2011, 6

[39] Murphy MM, Lawson JA, Mathew SJ, Hutcheson DA, Kardon G. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development, 2011, 138: 3625-3637

[40] Logan M et al. Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis, 2002, 33: 77-80

[41] Mitchell KJ et al. Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat. Cell Biol., 2010, 12: 257-266

[42] Tseng H-W et al. Neurogenic heterotopic ossifications develop independently of granulocyte colony-stimulating factor and neutrophils. J. Bone Miner. Res., 2020, 35: 2242-2251

[43] Loder SJ et al. Characterizing the circulating cell populations in traumatic heterotopic ossification. Am. J. Pathol., 2018, 188: 2464-2473

[44] Yu PB et al. BMP type I receptor inhibition reduces heterotopic ossification. Nat. Med, 2008, 14: 1363-1369

[45] Strong, A. L. et al. Bone morphogenetic protein ligand trap ALK3-Fc attenuates osteogenesis and heterotopic ossification in blast-related lower extremity trauma. Stem Cells Dev. 30, 91–105 (2020).

[46] Goloviznina, N. A. et al. Mesenchymal Stromal Cell-derived Extracellular Vesicles Promote Myeloid-biased Multipotent Hematopoietic Progenitor Expansion via Toll-Like Receptor Engagement. J. Biol. Chem. 291, 24607–24617 (2016).

[47] Grenier-Pleau, I. & Abraham, S. A. Extracellular vesicles tell all: how vesicle-mediated cellular communication shapes hematopoietic stem cell biology with increasing age. Exp. Hematol. 101–102, 7–15 (2021).

[48] Lecourt S et al. Characterization of distinct mesenchymal-like cell populations from human skeletal muscle in situ and in vitro. Exp. Cell Res., 2010, 316: 2513-2526

[49] Naldaiz-Gastesi, N. et al. Identification and characterization of the dermal panniculus carnosus muscle stem cells. Stem Cell Rep. 7, 411–424 (2016).

[50] Fujimaki S et al. Notch1 and Notch2 coordinately regulate stem cell function in the quiescent and activated states of muscle satellite cells. Stem Cells, 2018, 36: 278-285

[51] Greenbaum A et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature, 2013, 495: 227-230

[52] Mangiavini L et al. Fibrosis and hypoxia-inducible factor-1α–dependent tumors of the soft tissue on loss of von hippel-lindau in mesenchymal progenitors. Am. J. Pathol., 2015, 185: 3090-3101

[53] Krueger, K. C. et al. Characterization of Cre recombinase activity for in vivo targeting of adipocyte precursor cells. Stem Cell Rep. 3, 1147–1158 (2014).

[54] Calo E et al. Rb regulates fate choice and lineage commitment in vivo. Nature, 2010, 466: 1110-1114

[55] Oishi T et al. Osteogenic differentiation capacity of human skeletal muscle-derived progenitor cells. PLoS One, 2013, 8: e56641

[56] Couteaux R, Mira J-C, d’Albis A. Regeneration of muscles after cardiotoxin injury I. Cytological aspects. Biol. Cell, 1988, 62: 171-182

[57] d’Albis A, Couteaux R, Janmot C, Roulet A, Mira J-C. Regeneration after cardiotoxin injury of innervated and denervated slow and fast muscles of mammals. Eur. J. Biochem, 1988, 174: 103-110

[58] Debaud, C. et al. Peripheral denervation participates in heterotopic ossification in a spinal cord injury model. PLoS One 12, e0182454 (2017).

[59] Bouvet-Gerbettaz S et al. Adaptive immune response inhibits ectopic mature bone formation induced by BMSCs/BCP/plasma composite in immune-competent mice. Tissue Eng. Part A, 2014, 20: 2950-2962

Funding

Department of Health | National Health and Medical Research Council (NHMRC)(1101620)

USA Department of Defense - Award W81XWH-15-1-0606